# XADLiME: eXplainable Alzheimer's Disease Likelihood Map Estimation via Clinically-guided Prototype Learning

arXiv: https://arxiv.org/abs/2207.13223 · HTML: https://mlsanity.com/paper/2207.13223/

## Key facts

- Cited by 1 papers in the map (data through 14 Oct 2026).
- Builds on 23 of its 63 references that are in the map.
- First posted on arXiv 27 Jul 2022.

## Builds on (most cited first, 23 of 23)

- [Deep Residual Learning for Image Recognition](https://mlsanity.com/paper/1512.03385/) (2015)
- [Distilling the Knowledge in a Neural Network](https://mlsanity.com/paper/1503.02531/) (2015)
- [Auto-Encoding Variational Bayes](https://mlsanity.com/paper/1312.6114/) (2013)
- [Prototypical Networks for Few-shot Learning](https://mlsanity.com/paper/1703.05175/) (2017)
- [Explainable Artificial Intelligence (XAI): Concepts, Taxonomies, Opportunities and Challenges toward Responsible AI](https://mlsanity.com/paper/1910.10045/) (2019)
- [This Looks Like That: Deep Learning for Interpretable Image Recognition](https://mlsanity.com/paper/1806.10574/) (2018)
- [Deep Learning for Case-Based Reasoning through Prototypes: A Neural Network that Explains Its Predictions](https://mlsanity.com/paper/1710.04806/) (2017)
- [Automated brain extraction of multi-sequence MRI using artificial neural networks](https://mlsanity.com/paper/1901.11341/) (2019)
- [Drug discovery with explainable artificial intelligence](https://mlsanity.com/paper/2007.00523/) (2020)
- [XProtoNet: Diagnosis in Chest Radiography with Global and Local Explanations](https://mlsanity.com/paper/2103.10663/) (2021)
- [Predicting brain age with deep learning from raw imaging data results in a reliable and heritable biomarker](https://mlsanity.com/paper/1612.02572/) (2016)
- [Interpretable and Steerable Sequence Learning via Prototypes](https://mlsanity.com/paper/1907.09728/) (2019)
- [IAIA-BL: A Case-based Interpretable Deep Learning Model for Classification of Mass Lesions in Digital Mammography](https://mlsanity.com/paper/2103.12308/) (2021)
- [Residual and Plain Convolutional Neural Networks for 3D Brain MRI Classification](https://mlsanity.com/paper/1701.06643/) (2017)
- [Longitudinal Self-Supervised Learning](https://mlsanity.com/paper/2006.06930/) (2020)
- [A Survey on Deep Learning for Neuroimaging-based Brain Disorder Analysis](https://mlsanity.com/paper/2005.04573/) (2020)
- [Data Augmentation in High Dimensional Low Sample Size Setting Using a Geometry-Based Variational Autoencoder](https://mlsanity.com/paper/2105.00026/) (2021)
- [Degenerative Adversarial NeuroImage Nets: Generating Images that Mimic Disease Progression](https://mlsanity.com/paper/1907.02787/) (2019)
- [Medical Transformer: Universal Brain Encoder for 3D MRI Analysis](https://mlsanity.com/paper/2104.13633/) (2021)
- [Visual Explanations From Deep 3D Convolutional Neural Networks for Alzheimer's Disease Classification](https://mlsanity.com/paper/1803.02544/) (2018)
- [Learn-Explain-Reinforce: Counterfactual Reasoning and Its Guidance to Reinforce an Alzheimer's Disease Diagnosis Model](https://mlsanity.com/paper/2108.09451/) (2021)
- [A model of brain morphological changes related to aging and Alzheimer's disease from cross-sectional assessments](https://mlsanity.com/paper/1905.09826/) (2019)
- [On the design of convolutional neural networks for automatic detection of Alzheimer's disease](https://mlsanity.com/paper/1911.03740/) (2019)

## Built on by (most cited first, 1 of 1)

- [Learning the irreversible progression trajectory of Alzheimer's disease](https://mlsanity.com/paper/2403.06087/) (2024)

## Abstract (arXiv)

Diagnosing Alzheimer's disease (AD) involves a deliberate diagnostic process owing to its innate traits of irreversibility with subtle and gradual progression. These characteristics make AD biomarker identification from structural brain imaging (e.g., structural MRI) scans quite challenging. Furthermore, there is a high possibility of getting entangled with normal aging. We propose a novel deep-learning approach through eXplainable AD Likelihood Map Estimation (XADLiME) for AD progression modeling over 3D sMRIs using clinically-guided prototype learning. Specifically, we establish a set of topologically-aware prototypes onto the clusters of latent clinical features, uncovering an AD spectrum manifold. We then measure the similarities between latent clinical features and well-established prototypes, estimating a "pseudo" likelihood map. By considering this pseudo map as an enriched reference, we employ an estimating network to estimate the AD likelihood map over a 3D sMRI scan. Additionally, we promote the explainability of such a likelihood map by revealing a comprehensible overview from two perspectives: clinical and morphological. During the inference, this estimated likelihood map served as a substitute over unseen sMRI scans for effectively conducting the downstream task while providing thorough explainable states.
